Clinoleic 20% 4 % (Soybean Oil EMULSION) 4 %

Clinoleic 20% 4% is an intravenous emulsion containing soybean oil, designed for nutritional support. This product provides essential fatty acids and calories for patients requiring parenteral nutrition.

Strength

4 %

Pack Size

100/250/350/500/1000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clinoleic 20% 4% is primarily used for intravenous nutrition in patients who cannot absorb nutrients through the digestive system. It supplies essential fatty acids and calories, supporting overall health and well-being. This emulsion is often used in clinical settings where oral or enteral nutrition is not feasible.

Side Effects

When administered intravenously, Clinoleic 20% 4% provides essential fatty acids and calories directly into the bloodstream. This can help maintain energy levels and support various bodily functions. Common effects may include improved nutritional status and overall well-being.

Precautions & Warnings

Clinoleic 20% 4% should be administered under medical supervision. It is important to follow proper handling and storage guidelines to ensure the emulsion remains stable and effective. Patients with known allergies to soybean oil or any of the components should avoid using this product.

Avoid Interactions

Clinoleic 20% 4% may interact with other medications or supplements when administered intravenously. It is important to inform healthcare providers about all current medications to avoid potential interactions. Always consult a healthcare professional before starting any new treatment.

Frequently Asked Questions

Clinoleic 20% 4% is used for intravenous nutrition, providing essential fatty acids and calories to patients who cannot absorb nutrients through the digestive system.

Clinoleic 20% 4% is administered intravenously, typically in a clinical setting under medical supervision.

Common effects may include improved nutritional status and overall well-being, as it provides essential fatty acids and calories directly into the bloodstream.

Patients with known allergies to soybean oil or any of the components should avoid using Clinoleic 20% 4%.

Yes, Clinoleic 20% 4% may interact with other medications or supplements. It is important to inform healthcare providers about all current medications to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.